Opsens (CVE:OPS – Get Rating) was downgraded by equities researchers at Raymond James from a “strong-buy” rating to an “outperform” rating in a report released on Wednesday, BayStreet.CA reports. They presently have a C$5.00 target price on the stock, down from their previous target price of C$6.00. Raymond James’ price target indicates a potential upside of 259.71% from the stock’s previous close.
Separately, Stifel Nicolaus lifted their target price on shares of Opsens from C$3.35 to C$3.75 in a research report on Thursday, September 29th.
Opsens Trading Down 0.7 %
Shares of Opsens stock opened at C$1.39 on Wednesday. The firm’s 50-day simple moving average is C$1.39 and its 200-day simple moving average is C$1.39. Opsens has a twelve month low of C$1.11 and a twelve month high of C$1.83.
Opsens Inc provides fiber optic sensing technology. The Company operates through two segments: Medical and Industrial. In Medical segment, the Company focuses on the measure of Fractional Flow Reserve (FFR) in interventional cardiology. In Industrial segment, it develops, manufactures and installs fiber optic sensing solutions for critical applications, such as the monitoring of oil wells and other industrial applications.
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Microsoft Shares: Is it Time to Back Up the Truck?
- Institutional Support for Analog Devices Remains High
- Three CBD Stocks to Dominate a Budding Industry
- Is the 60/40 Portfolio Mix Still in Vogue?
Receive News & Ratings for Opsens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opsens and related companies with MarketBeat.com's FREE daily email newsletter.